On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-1...
Read More
Welcome to the 24th edition of our newsletter on developments in the automotive industry published by Morgan Lewis’s automotive & mobility team with contributions from lawyers in our offices around the globe. We counsel our automotive clients on a broad range of industry-specific issues, including matters relating to mergers and acquisitions, antitrust, litigation, regulatory concerns intellectual property, and labor and employment. Please see full Publication below for more information....By:...
Read More
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....By: Goodwin
Read More
On July 9, 2020, in an en banc opinion authored by Chief Justice Collins J. Seitz, Jr., the Delaware Supreme Court affirmed a decision by the Delaware Court of Chancery, which relied on the unaffected stock price of Jarden Corporation to determine its fair value in a post-merger appraisal action. Fir Tree Value Master Fund, LP v. Jarden Corp., No. 454, 2019 (Del. July 9, 2020). “Although it is not often that a corporation’s unaffected market price alone could support fair value,” explained th...
Read More
Linear infrastructure projects, including oil and gas pipelines, electric transmission lines and transportation, have faced a number of regulatory challenges in recent months. Some of these challenges stem from changes in regulatory schemes or adverse court holdings, while others stem from uncertainty of pending Endangered Species Act (ESA) listing decisions and other actions....By: Nossaman LLP
Read More
OPEC and its oil-producing allies (in Russia and elsewhere) are reportedly working on a plan to ease cuts on oil production they agreed upon in April “amid signs that demand is returning to normal levels following coronavirus-related lockdowns” and internal pressure from the Saudis....By: Robins Kaplan LLP
Read More
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular, it covers amendments to the Rules Governing the Listing of Securities on HKEx (Listing Rules) as well as announcements, guidance and enforcement-related news from HKEx and the Securities and Futures Commission (SFC). From time to time it will also cover other recent market....
Read More
The final Vertical Merger Guidelines issued on June 30, 2020 provide guidance to the business and legal communities on how the Department of Justice (“DOJ”) and Federal Trade Commission (“FTC”) currently analyze the competitive impact of vertical mergers. The new guidelines apply to strictly vertical mergers (combinations of firms or assets at different stages of the same supply chain), “diagonal” mergers (combinations of firms or assets at different stages of competing supply chains), and...
Read More
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. In this episode, I visit Dr. Gleb Tsipursky, who is known as the Disaster Avoidance Expert. He has over 20 years of experience dramatically empowering leaders and organizations to avoid business disasters by addressing potential threats, maximizing unexpected opportunities, and resolving persistent personnel problems. Dr. Tsipursky is a bestselling author of several books, including on avoiding...By: T...
Read More
On May 21, 2020, the Securities and Exchange Commission (the “SEC”) amended the financial statement and other disclosure requirements that apply when public companies acquire or dispose of a business or real estate operations. The amendments simplify and rationalize the current rules, and should on balance decrease the regulatory burdens on public companies. The amendments continue the SEC’s focus on reducing the regulatory burdens on public companies and facilitating access to public capital...
Read More